Current Trends In Biologics-Related Inter Partes Reviews
Inter partes review is increasingly becoming the method of choice for challenging patents directed to blockbuster biopharmaceuticals and methods of their manufacture. Examples include challenges to patents relating to aging biologics such...To view the full article, register now.
Already a subscriber? Click here to view full article